# Ernexa Therapeutics Inc.: Form S-1, filed Nov 5, 2024

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: S-1
- Filed: 2024-11-05
- Accepted by EDGAR: Nov 5, 2024, 16:30 ET
- Period: not reported
- Accession: 0001493152-24-043663
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000149315224043663/forms-1.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000149315224043663/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000149315224043663/forms-1.htm

Filed Nov 5, 2024.
Source: SEC EDGAR, the filing index for accession 0001493152-24-043663. Last ingested by Listed: Nov 6, 2026, 17:52 ET. No prices; not investment advice.